• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delta 放射组学特征可提高肺癌发病率预测:国家肺癌筛查试验的巢式病例对照分析。

Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial.

机构信息

Department of Computer Sciences and Engineering, University of South Florida, Tampa, Florida.

Department of Cancer Physiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

出版信息

Cancer Med. 2018 Dec;7(12):6340-6356. doi: 10.1002/cam4.1852. Epub 2018 Dec 1.

DOI:10.1002/cam4.1852
PMID:30507033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6308046/
Abstract

BACKGROUND

Current guidelines for lung cancer screening increased a positive scan threshold to a 6 mm longest diameter. We extracted radiomic features from baseline and follow-up screens and performed size-specific analyses to predict lung cancer incidence using three nodule size classes (<6 mm [small], 6-16 mm [intermediate], and ≥16 mm [large]).

METHODS

We extracted 219 features from baseline (T0) nodules and 219 delta features which are the change from T0 to first follow-up (T1). Nodules were identified for 160 incidence cases diagnosed with lung cancer at T1 or second follow-up screen (T2) and for 307 nodule-positive controls that had three consecutive positive screens not diagnosed as lung cancer. The cases and controls were split into training and test cohorts; classifier models were used to identify the most predictive features.

RESULTS

The final models revealed modest improvements for baseline and delta features when compared to only baseline features. The AUROCs for small- and intermediate-sized nodules were 0.83 (95% CI 0.76-0.90) and 0.76 (95% CI 0.71-0.81) for baseline-only radiomic features, respectively, and 0.84 (95% CI 0.77-0.90) and 0.84 (95% CI 0.80-0.88) for baseline and delta features, respectively. When intermediate and large nodules were combined, the AUROC for baseline-only features was 0.80 (95% CI 0.76-0.84) compared with 0.86 (95% CI 0.83-0.89) for baseline and delta features.

CONCLUSIONS

We found modest improvements in predicting lung cancer incidence by combining baseline and delta radiomics. Radiomics could be used to improve current size-based screening guidelines.

摘要

背景

目前的肺癌筛查指南将阳性扫描阈值提高到最长直径 6 毫米。我们从基线和随访筛查中提取了放射组学特征,并使用三个结节大小类别(<6 毫米[小]、6-16 毫米[中]和≥16 毫米[大])进行了特定大小的分析,以预测肺癌的发病率。

方法

我们从基线(T0)结节中提取了 219 个特征,并从 T0 到第一次随访(T1)提取了 219 个差值特征。为 160 例在 T1 或第二次随访筛查(T2)时被诊断为肺癌的病例和 307 例经三次连续阳性筛查且未被诊断为肺癌的结节阳性对照提取了结节。病例和对照组被分为训练和测试队列;使用分类器模型来识别最具预测性的特征。

结果

与仅基线特征相比,基线和差值特征的最终模型显示出了适度的改进。小和中结节的基线特征的 AUROC 分别为 0.83(95%CI 0.76-0.90)和 0.76(95%CI 0.71-0.81),而基线和差值特征的 AUROC 分别为 0.84(95%CI 0.77-0.90)和 0.84(95%CI 0.80-0.88)。当将中等和大结节合并时,仅基线特征的 AUROC 为 0.80(95%CI 0.76-0.84),而基线和差值特征的 AUROC 为 0.86(95%CI 0.83-0.89)。

结论

我们发现通过结合基线和差值放射组学,在预测肺癌发病率方面有适度的提高。放射组学可用于改进当前基于大小的筛查指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/a6354d772432/CAM4-7-6340-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/f611336ee07c/CAM4-7-6340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/e88d798a5c09/CAM4-7-6340-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/a6354d772432/CAM4-7-6340-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/f611336ee07c/CAM4-7-6340-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/e88d798a5c09/CAM4-7-6340-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d96/6308046/a6354d772432/CAM4-7-6340-g003.jpg

相似文献

1
Delta radiomic features improve prediction for lung cancer incidence: A nested case-control analysis of the National Lung Screening Trial.Delta 放射组学特征可提高肺癌发病率预测:国家肺癌筛查试验的巢式病例对照分析。
Cancer Med. 2018 Dec;7(12):6340-6356. doi: 10.1002/cam4.1852. Epub 2018 Dec 1.
2
Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.在国家肺癌筛查试验中,放射语义特征与 Lung-RADS 预测筛查性肺结节恶性肿瘤的比较。
Clin Lung Cancer. 2018 Mar;19(2):148-156.e3. doi: 10.1016/j.cllc.2017.10.002. Epub 2017 Oct 13.
3
Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.低剂量 CT 肺癌筛查中新出现实性结节的发生率和肺癌概率:来自随机、对照 NELSON 试验的数据分析。
Lancet Oncol. 2016 Jul;17(7):907-916. doi: 10.1016/S1470-2045(16)30069-9. Epub 2016 Jun 6.
4
Optimizing the timing of diagnostic testing after positive findings in lung cancer screening: a proof of concept radiomics study.优化肺癌筛查阳性发现后的诊断检测时机:一项概念验证的放射组学研究。
J Transl Med. 2021 May 4;19(1):191. doi: 10.1186/s12967-021-02849-8.
5
Predicting malignant potential of subsolid nodules: can radiomics preempt longitudinal follow up CT?预测亚实性结节的恶性潜能:放射组学能否预测纵向随访 CT?
Cancer Imaging. 2019 Jun 10;19(1):36. doi: 10.1186/s40644-019-0223-7.
6
Predicting Malignant Nodules from Screening CT Scans.通过筛查CT扫描预测恶性结节
J Thorac Oncol. 2016 Dec;11(12):2120-2128. doi: 10.1016/j.jtho.2016.07.002. Epub 2016 Jul 13.
7
Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.国家肺癌筛查试验中与新实性结节相关的肺癌风险
AJR Am J Roentgenol. 2017 Nov;209(5):1009-1014. doi: 10.2214/AJR.17.18252. Epub 2017 Sep 12.
8
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.CT 检测到肺结节患者的肺癌概率:来自低剂量 CT 筛查 NELSON 试验数据的预设分析。
Lancet Oncol. 2014 Nov;15(12):1332-41. doi: 10.1016/S1470-2045(14)70389-4. Epub 2014 Oct 1.
9
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.国家肺癌筛查试验CT组中,患病率、间期及筛查发现的肺癌患者预后差异。
PLoS One. 2016 Aug 10;11(8):e0159880. doi: 10.1371/journal.pone.0159880. eCollection 2016.
10
Multi-window CT based Radiomic signatures in differentiating indolent versus aggressive lung cancers in the National Lung Screening Trial: a retrospective study.基于多窗口 CT 的放射组学特征在 NLST 中鉴别惰性与侵袭性肺癌:一项回顾性研究。
Cancer Imaging. 2019 Jun 28;19(1):45. doi: 10.1186/s40644-019-0232-6.

引用本文的文献

1
A Holistic Approach to Implementing Artificial Intelligence in Lung Cancer.肺癌中实施人工智能的整体方法。
Indian J Surg Oncol. 2025 Feb;16(1):257-278. doi: 10.1007/s13193-024-02079-6. Epub 2024 Sep 5.
2
Data augmented lung cancer prediction framework using the nested case control NLST cohort.使用巢式病例对照NLST队列的数据增强肺癌预测框架。
Front Oncol. 2025 Feb 25;15:1492758. doi: 10.3389/fonc.2025.1492758. eCollection 2025.
3
A benchmark of deep learning approaches to predict lung cancer risk using national lung screening trial cohort.

本文引用的文献

1
Combined Biomarker and Computed Tomography Screening Strategies for Lung Cancer: Projections of Health and Economic Tradeoffs in the US Population.肺癌的联合生物标志物与计算机断层扫描筛查策略:美国人群健康与经济权衡的预测
MDM Policy Pract. 2016 Jul-Dec;1(1). doi: 10.1177/2381468316643968. Epub 2016 Jul 7.
2
Deep Feature Transfer Learning in Combination with Traditional Features Predicts Survival Among Patients with Lung Adenocarcinoma.深度特征迁移学习结合传统特征可预测肺腺癌患者的生存率。
Tomography. 2016 Dec;2(4):388-395. doi: 10.18383/j.tom.2016.00211.
3
Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
使用国家肺癌筛查试验队列预测肺癌风险的深度学习方法基准。
Sci Rep. 2025 Jan 11;15(1):1736. doi: 10.1038/s41598-024-84193-7.
4
Differential Radiomics-Based Signature Predicts Lung Cancer Risk Accounting for Imaging Parameters in NLST Cohort.基于放射组学差异的签名可预测 NLST 队列中考虑成像参数的肺癌风险。
Cancer Med. 2024 Oct;13(20):e70359. doi: 10.1002/cam4.70359.
5
Development and validation of an interpretable delta radiomics-based model for predicting invasive ground-glass nodules in lung adenocarcinoma: a retrospective cohort study.基于可解释性Delta放射组学模型预测肺腺癌侵袭性磨玻璃结节的研究与验证:一项回顾性队列研究
Quant Imaging Med Surg. 2024 Jun 1;14(6):4086-4097. doi: 10.21037/qims-23-1711. Epub 2024 May 24.
6
Application of radiomics in diagnosis and treatment of lung cancer.放射组学在肺癌诊断与治疗中的应用。
Front Pharmacol. 2023 Nov 1;14:1295511. doi: 10.3389/fphar.2023.1295511. eCollection 2023.
7
Multi-Biomarkers Panel in Identifying Benign and Malignant Lung Diseases and Pathological Types of Lung Cancer.用于鉴别良性和恶性肺部疾病及肺癌病理类型的多生物标志物检测板
J Cancer. 2023 Jun 26;14(10):1904-1912. doi: 10.7150/jca.85846. eCollection 2023.
8
Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules.肺结节良恶性评估的生物标志物研究进展。
Chest. 2023 Oct;164(4):1028-1041. doi: 10.1016/j.chest.2023.05.025. Epub 2023 May 25.
9
Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodules.纵向肺癌预测卷积神经网络模型提高了不确定肺结节的分类。
Sci Rep. 2023 Apr 15;13(1):6157. doi: 10.1038/s41598-023-33098-y.
10
Deep learning-based algorithm improves radiologists' performance in lung cancer bone metastases detection on computed tomography.基于深度学习的算法提高了放射科医生在计算机断层扫描中检测肺癌骨转移的性能。
Front Oncol. 2023 Feb 8;13:1125637. doi: 10.3389/fonc.2023.1125637. eCollection 2023.
携带ALK重排或EGFR突变的手术切除肺腺癌的临床及CT特征
Eur J Radiol. 2016 Nov;85(11):1934-1940. doi: 10.1016/j.ejrad.2016.08.023. Epub 2016 Aug 30.
4
Radiological Image Traits Predictive of Cancer Status in Pulmonary Nodules.预测肺结节癌症状态的放射学图像特征
Clin Cancer Res. 2017 Mar 15;23(6):1442-1449. doi: 10.1158/1078-0432.CCR-15-3102. Epub 2016 Sep 23.
5
Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.国家肺癌筛查试验CT组中,患病率、间期及筛查发现的肺癌患者预后差异。
PLoS One. 2016 Aug 10;11(8):e0159880. doi: 10.1371/journal.pone.0159880. eCollection 2016.
6
Predicting Malignant Nodules from Screening CT Scans.通过筛查CT扫描预测恶性结节
J Thorac Oncol. 2016 Dec;11(12):2120-2128. doi: 10.1016/j.jtho.2016.07.002. Epub 2016 Jul 13.
7
Biomarkers of risk to develop lung cancer in the new screening era.在新的筛查时代,肺癌风险的生物标志物。
Ann Transl Med. 2016 Apr;4(8):158. doi: 10.21037/atm.2016.03.46.
8
Association Between Computed Tomographic Features and Kirsten Rat Sarcoma Viral Oncogene Mutations in Patients With Stage I Lung Adenocarcinoma and Their Prognostic Value.I期肺腺癌患者计算机断层扫描特征与 Kirsten 大鼠肉瘤病毒癌基因突变之间的关联及其预后价值
Clin Lung Cancer. 2016 Jul;17(4):271-8. doi: 10.1016/j.cllc.2015.11.002. Epub 2015 Nov 12.
9
Radiomics: Images Are More than Pictures, They Are Data.放射组学:图像不止是图片,它们是数据。
Radiology. 2016 Feb;278(2):563-77. doi: 10.1148/radiol.2015151169. Epub 2015 Nov 18.
10
Noninvasive Quantitative Imaging-based Biomarkers and Lung Cancer Screening.基于非侵入性定量成像的生物标志物与肺癌筛查。
Am J Respir Crit Care Med. 2015 Sep 15;192(6):654-6. doi: 10.1164/rccm.201506-1160ED.